Essential Partners’s Korro Bio KRRO Stock Holding History

Essential Partners’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$605	Sell	61 -119	-66%	-$1.46K	﹤0.01%	2339
2026 Q2	$2.37K	Sell	180 -1,142	-86%	-$14.2K	﹤0.01%	1907
2026 Q1	$15K	Buy	+1,322	New	+$14.6K	0.01%	1048
2025 Q4	–	Sell	-394	Closed	-$18.9K	–	2849
2025 Q3	$18.9K	Buy	394 +391	+13,033%	+$8.68K	0.01%	912
2025 Q2	$37	Buy	+3	New	+$43	﹤0.01%	2176

Other funds holding KRRO

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Essential Partners's KRRO Position: Q3 2026 in Review

Essential Partners reduced its Korro Bio (KRRO) stake by 66% in Q3 2026, selling an estimated $1.46K and leaving 61 shares worth $605. The position accounts for ﹤0.01% of the portfolio, ranked #2339.

Essential Partners first reported a position in KRRO in Q2 2025 and has held it in 5 quarters since. The position peaked at $18.9K in Q3 2025. 8 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

Essential Partners held 61 shares of Korro Bio worth $605 as of Q3 2026.
Essential Partners sold 119 Korro Bio shares in Q3 2026, an estimated $1.46K.
Korro Bio made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2339 holding.
Essential Partners first reported a position in Korro Bio in Q2 2025 and has held it in 5 quarters since.
Essential Partners's Korro Bio position peaked at $18.9K in Q3 2025.
8 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.